Maria Inês Amaro

Maria Inês Amaro

Auto-generated profile, based on publicly available information

Maria Inês Amaro

Synthesis and Solid State Pharmaceutical Centre, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ASAlice Simon
Alice Simon
MAMaria Inês Amaro
Maria Inês Amaro
LCLucio Cabral
Lucio Cabral
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
VSValeria De Sousa
Valeria De Sousa

1 April 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
MAMaria Inês Amaro
Maria Inês Amaro
FTFrederic Tewes
Frederic Tewes
Oliviero L. GobboOliviero L. Gobbo
Oliviero L. Gobbo
Lidia TajberLidia Tajber
Lidia Tajber
OCOwen I. Corrigan
Owen I. Corrigan
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
A challenge exists to produce dry powder inhaler (DPI) formulations with appropriate formulation stability, biological activity and suitable physicochemical and aerosolisation characteristics that provide a viable alternative to parenteral formulations. The present study aimed to produce sugar-based nanoporous/nanoparticulate microparticles (NPMPs) loaded with a therapeutic peptide - salmon calcitonin (sCT). The physicochemical properties of the powders and their suitability for pulmonary delivery of sCT were determined. Production of powders composed of sCT loaded into raffinose or trehalose with or without hydroxypropyl-β-cyclodextrin was carried out using a laboratory scale spray dryer. Spray dried microparticles were spherical, porous and of small geometric size (≤2 μm). Aerodynamic assessment showed that the fine particle fraction (FPF) less than 5 μm ranged from 45 to 86%, depending on the formulation. The mass median aerodynamic diameter (MMAD) varied between 1.9 and 4.7 μm. Compared to unprocessed sCT, sCT:raffinose composite systems presented a bioactivity of approximately 100% and sCT:trehalose composite systems between 70-90% after spray drying. Storage stability studies demonstrated composite systems with raffinose to be more stable than those containing trehalose. These sugar-based salmon calcitonin-loaded NPMPs retain reasonable sCT bioactivity and have micromeritic and physicochemical properties which indicate their suitability for pulmonary delivery. Formulations presented a similar pharmacokinetic profile to sCT solution. Hence the advantage of a dry powder formulation is its non-invasive delivery route and ease of administration of the sCT.

1 October 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ÉSÉrika Yoko Suzuki
Érika Yoko Suzuki
MAMaria Inês Amaro
Maria Inês Amaro
GAGabriella Silva de Almeida
Gabriella Silva de Almeida
LCLucio Mendes Cabral
Lucio Mendes Cabral
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
VSValeria De Sousa
Valeria De Sousa

1 November 2015 in Solid State Sciences
Verified
Journal Article
Open access
MAMaria Inês Amaro
Maria Inês Amaro
ASAlice Simon
Alice Simon
LCLúcio Mendes Cabral
Lúcio Mendes Cabral
VSValéria Pereira de Sousa
Valéria Pereira de Sousa
AHAnne Marie Healy
Anne Marie Healy